kontakt

About Us

leeza

Leeza Osipenko, PhD

Consilium Scientific CEO

Leeza gained experience in academia, consulting and public sector before establishing Consilium Scientific in 2020. After completing PhD in Systems Engineering in the USA, she came to England. Her career started at the University of Warwick Medical School where she worked as Senior Research Fellow on evaluating non-invasive foetal DNA tests. Then she relocated to London and joined a consulting company as Principal Economist leading on projects for NICE and other UK public sector departments. Leeza is an expert in Health Technology Assessment and between 2014 and 2018 she served as a Director of NICE Scientific Advice. Her academic work focuses on examining the status quo of clinical research, through quality improvement, transparency, and methodological rigour. In particular, she is interested in clinical data integrity, health policy, applied clinical research, and clinical trial design. Between 2018 and 2021 Leeza was a Senior Lecturer in Practice at the London School of Economics (LSE) Department of Health Policy and currently she is a Senior Visiting Fellow at LSE Health.

leeza

Lisa Hutchinson, PhD

Lisa gained her first class honours degree in biochemistry from University College London and her PhD at the Institute of Cancer Research. Her career spans more than 17 years in science and clinical publishing, with her first appointment as Assistant Editor and soon promoted to Journal Editor of Breast Cancer Research. Lisa was the Founding Chief Editor of Nature Reviews Clinical Oncology, which she launched in 2004. As Chief Editor for 14 years, she has written numerous editorials and more than 300 research highlight publications, and has forged multiple collaborations within the oncology community. She is a member of the non-profit DFMO Task Force that has initiated a maintenance phase II trial for patients with high-risk neuroblastoma. Currently, Lisa is a freelance Consultant and has worked for the charitable organisation, the Foundation for World Health, and more recently Consilium Scientific.

leeza

Bernardo Perez Villa, MD, MSc

Bernardo is a Research Supervisor at Cleveland Clinic Florida, USA. He is a cardiologist with 10 years of experience across different healthcare systems. Bernardo completed his MD in Mendoza, Argentina and then received training as a cardiologist at Hospital del Mar in Barcelona, Spain. After finishing his residency, he worked in a county hospital, helping build the heart failure unit from scratch, and developed a mobile application to improve the quality of care for heart failure patients. Between 2018 and 2020 Bernardo was the Chief Science Officer at Wellian, a digital health start-up based in Boulder, USA. In 2021 he completed an MSc in Health Economics, Management and Outcomes in Cardiovascular Science at the London School of Economics. At Consilium, Bernardo supports the seminar programme and other educational initiatives.

leeza

Sofia Huertas Carrera, MSc

Sofia is a registered Pharmacist specialising in research methodology. She trained in Public Health at York University. During her career in primary care, she collaborated with key stakeholders in the strategic health needs assessment for North Yorkshire. Working in medical research she has developed expertise in systematic reviews and risk of bias assessments. Prior to joining Consilium Scientific, she was part of the NIHR commissioned Evidence Review Group working on health technology assessments. She is currently learning how to build cost-effectiveness economic models at ScHARR.

leeza

Pierre Siouti, MSc

Based in Paris, Pierre works as an Operation Manager at Consilium Scientific. He is also working as a Graduate Teaching Assistant at a French Business School with specialisations in Business Development, Business Negotiation, and Innovation Management. His Master's degree in Health Policy, from the London School of Economics and the London School of Hygiene and Tropical Medicine, helped him to gain an in-depth understanding of current international health policy issues. Pierre studied dentistry while clinically handling patients at the hospital. He also obtained a master's degree in Public Health from the University of Paris Saclay. His research interests lie in strengthening health systems in Low-and-Middle-Income Countries and enhancing clinical researches' transparency and ethics.

leeza

 

Julien Hogg

Julien is completing his BA in Psychology at McGill University, focusing his research on the effects of pharmacological treatments on hormonal and behavioural psychology. He is interested in clinical psychology, including novel psychiatric treatments and broader public health policy in North America and Europe. Julien joined Consiliium in June 2021 as a research assistant and working with the team on the Health on Trial projects. 

leeza

Davide Santambrogio

Davide is a Data Scientist with a Computer Science and Engineering degree at Politecnico di Milano. He attended a double degree program with the University of Illinois at Chicago working also as a Graduate Research Assistant on an Arduino device for ankle rehabilitation. He worked on a Reinforcement Learning research thesis about Risk Aversion and the MDP modification, graduating in 2020. Then, after an Internship at Amazon in Luxembourg, he started to work in Milan at Moviri as Data Scientist and as a freelance at Consilium. He is an expert in Machine Learning and Deep Learning with a particular interest in Statistics and Data Analysis. 

leeza

Joude Cachoux
 
Joude is a research assistant at Consilium Scientific. She graduated from Pharmacy at the University of Paris-Saclay, where she specialized in the pharmaceutical industry sector. After completing a Master of Public Health at the French School of Public Health (EHESP), she worked in the health division of the OECD, where she gained experience in health policy, patient-centered care, and patient-reported indicators for healthcare quality improvement. Currently, her work focuses on the place of Patient-Reported Outcomes in the clinical development and market access of health technologies. Her research interests are health policy, patient-centered care, value-based health care, clinical trials, and health technology assessment.